declines in Betaseron, a top drug for Bayer .Both the material science and the ..... differentiation from the older version. Bayer is in the midst of launching several ..... drugs that hold blockbuster potential. Bayer 's strong entrenchment in biologics
Sept 18 (Reuters) - Bayer AG : * Shares indicated up 2.3 percent after report it plans to separate its
FRANKFURT, Sept 18 (Reuters) - Bayer plans to sell its plastics business with an estimated value of about 8 billion euros ($10.3 billion) as part of a shift away from chemicals towards pharmaceuticals and crop science, a German newspaper reported, citing informed sources.
Sept 16 (Reuters) - Bayer AG : * Says initiates phase III trial of ODM-201 in men with high-risk
WASHINGTON, Sept 12 (Reuters) - The American unit of Bayer AG is making unsubstantiated claims about its Phillips Colon Health product, the United States said on Friday as it sought to hold Bayer ...
Covidien, he was CEO of Bayer Healthcare 's U.S. pharmaceutical ..... experience at a firm like Bayer , which also has a broad ..... four segments: generic pharmaceuticals , branded pharmaceuticals , nuclear imaging, and
Sept 8 (Reuters) - Bayer AG : * Says safety and sustained benefits of adempas from Bayer confirmed by
By Samreen Agha : Spectrum Pharmaceuticals , Inc. ( SPPI ) is a small-cap biotechnology ..... with a number of companies, such as Hanmi Pharmaceuticals , Ligand Pharmaceuticals , Bayer , Biogen Idec, Mundipharma, TopoTarget
Gilead is now a larger company ($160 B market cap) than many familiar pharma names including Sanofi, Lilly, AbbVie, Bayer AG , Bristol-Myers-Squibb, GlaxoSmithKline, AstraZeneca, Novo Nordisk, and Amgen. Gilead is rapidly approaching the
major pharma company Sanofi (NYSE: SNY ). In addition to growth in ophthalmology, with which REGN partners with Bayer Healthcare , the greatest amount of pipeline excitement comes from the REGN injectable protein alirocumab. This is a cholesterol